Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederico Guilherme Graeff

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Acta Neuropsychiatrica|January 5, 2024
Bradykinin actions in the central nervous system: historical overview and psychiatric implicationsFrederico Guilherme Graeff, Sâmia Joca, Helio Zangrossi
Neural Plasticity|March 14, 2009
Panic disorder: is the PAG involved?Cristina Marta Del-Ben, Frederico Guilherme Graeff
Neuroscience and Biobehavioral Reviews|October 4, 2014
Experimental public speaking: contributions to the understanding of the serotonergic modulation of fearCybele Garcia-Leal, Frederico Guilherme Graeff, Cristina Marta Del-Ben
CNS & Neurological Disorders Drug Targets|September 10, 2015
New Findings on the Neurotransmitter Modulation of Defense in the Dorsal Periaqueductal GrayFrederico Guilherme Graeff, Ana Beatriz Sant'Ana, Heloísa Helena Vilela-Costa, et al.
Behavioural Brain Research|July 19, 2017
What we imagine is what we do? A critical overview about mental imagery as a strategy to study human defensive responsesRosana Shuhama, D Caroline Blanchard, Frederico Guilherme Graeff, et al.
Current Pharmaceutical Design|January 8, 2015
Early life stress in depressive patients: role of glucocorticoid and mineralocorticoid receptors and of hypothalamic-pituitary-adrenal axis activityMario Francisco Juruena, Cristiane Von Werne Baes, Itiana Castro Menezes, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2013
The 5-HT1D/1B receptor agonist sumatriptan enhances fear of simulated speaking and reduces plasma levels of prolactinMarcos Gonçalves de Rezende, Cybele Garcia-Leal, Frederico Guilherme Graeff, et al.
Neuroscience Letters|March 23, 2011
Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-mazeVânia Ramos Sela, Carla Biesdorf, Diego Henrique Ramos, et al.
Expert Opinion on Drug Discovery|January 31, 2025
Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approachesAline Silva de Miranda, Eliana C B Toscano, Venugopal Reddy Venna, et al.
Neuropharmacology|May 31, 2017
Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptorsCaio César Sestile, Jhonatan Christian Maraschin, Vanessa Scalco Gama, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Acta Neuropsychiatrica|January 5, 2024
Bradykinin actions in the central nervous system: historical overview and psychiatric implicationsFrederico Guilherme Graeff, Sâmia Joca, Helio Zangrossi
Neural Plasticity|March 14, 2009
Panic disorder: is the PAG involved?Cristina Marta Del-Ben, Frederico Guilherme Graeff
Neuroscience and Biobehavioral Reviews|October 4, 2014
Experimental public speaking: contributions to the understanding of the serotonergic modulation of fearCybele Garcia-Leal, Frederico Guilherme Graeff, Cristina Marta Del-Ben
CNS & Neurological Disorders Drug Targets|September 10, 2015
New Findings on the Neurotransmitter Modulation of Defense in the Dorsal Periaqueductal GrayFrederico Guilherme Graeff, Ana Beatriz Sant'Ana, Heloísa Helena Vilela-Costa, et al.
Behavioural Brain Research|July 19, 2017
What we imagine is what we do? A critical overview about mental imagery as a strategy to study human defensive responsesRosana Shuhama, D Caroline Blanchard, Frederico Guilherme Graeff, et al.
Current Pharmaceutical Design|January 8, 2015
Early life stress in depressive patients: role of glucocorticoid and mineralocorticoid receptors and of hypothalamic-pituitary-adrenal axis activityMario Francisco Juruena, Cristiane Von Werne Baes, Itiana Castro Menezes, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2013
The 5-HT1D/1B receptor agonist sumatriptan enhances fear of simulated speaking and reduces plasma levels of prolactinMarcos Gonçalves de Rezende, Cybele Garcia-Leal, Frederico Guilherme Graeff, et al.
Neuroscience Letters|March 23, 2011
Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-mazeVânia Ramos Sela, Carla Biesdorf, Diego Henrique Ramos, et al.
Expert Opinion on Drug Discovery|January 31, 2025
Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approachesAline Silva de Miranda, Eliana C B Toscano, Venugopal Reddy Venna, et al.
Neuropharmacology|May 31, 2017
Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptorsCaio César Sestile, Jhonatan Christian Maraschin, Vanessa Scalco Gama, et al.
Pageof 2